SPEED survey measures dry eye symptoms

Article

The Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire is a repeatable and valid method to measure dry eye symptoms, reveals a recent paper in the journal Cornea.

The Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire is a repeatable and valid method to measure dry eye symptoms, reveals a recent paper in the journal Cornea.

Dr William Ngo et al., Centre for Contact Lens Research, University of Waterloo, Waterloo, Ontario, Canada, conducted a study on 50 subjects, with 30 as identified as symptomatic and 20 asymptomatic. The SPEED questionnaire was used on all patients, as well as the McMonnies dry eye survey, the Ocular Surface Disease Index (OSDI), dry eye questionnaire and subjective evaluation of symptoms.

All questionnaires were completed in a random order two visits, with clinical measurements obtained on the first visit. Concordance correlation coefficient was used to determine repeatability, whereas Rasch analyses, principal component and factor was used to determine dimensionality. SPEED scores were compared with dry eye diagnosis based on OSDI to measure validity.

SPEED survey data was undimensional and repeatable, with the three principal symptoms of dry eye identified. This included dryness, burning and soreness/fatigue. The only clinical measures that strongly correlated with SPEED questionnaire scores were corneal staining, meibomian gland score and meibomian glands yielding liquid secretion score.

To read the abstract please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.